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a b s t r a c t
Haploinsufﬁciency of Euchromatin histone methyltransferase 1 (EHMT1), a chromatin modifying enzyme, is
the cause of Kleefstra syndrome (KS). KS is an intellectual disability (ID) syndrome, with general developmental
delay, hypotonia, and craniofacial dysmorphisms as additional core features. Recent studies have been focused
on the role of EHMT1 in learning and memory, linked to the ID phenotype of KS patients. In this study we used
the Ehmt1þ / mouse model, and investigated whether the core features of KS were mimicked in these mice.
When comparing Ehmt1þ / mice to wildtype littermates we observed delayed postnatal growth, eye opening,
ear opening, and upper incisor eruption, indicating a delayed postnatal development. Furthermore, tests for
muscular strength and motor coordination showed features of hypotonia in young Ehmt1þ / mice. Lastly, we
found that Ehmt1þ / mice showed brachycephalic crania, a shorter or bent nose, and hypertelorism,
reminiscent of the craniofacial dysmorphisms seen in KS. In addition, gene expression analysis revealed a
signiﬁcant upregulation of the mRNA levels of Runx2 and several other bone tissue related genes in P28
Ehmt1þ / mice. Runx2 immunostaining also appeared to be increased. The mRNA upregulationwas associated
with decreased histone H3 lysine 9 dimethylation (H3K9me2) levels, the epigenetic mark deposited by Ehmt1,
in the promoter region of these genes. Together, Ehmt1þ / mice indeed recapitulate KS core features and can
be used as an animal model for Kleefstra syndrome. The increased expression of bone developmental genes in
the Ehmt1þ / mice likely contributes to their cranial dysmorphisms and might be explained by diminished
Ehmt1-induced H3K9 dimethylation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Kleefstra syndrome (KS) is a recently deﬁned intellectual
disability (ID) syndrome, caused by haploinsufﬁciency of the
Euchromatin histone methyltransferase 1 (EHMT1) gene (Kleefstra
et al., 2006, 2009, 2010, 2012). Mouse Ehmt1/GLP/KMT1D forms
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a heteromeric complex with Ehmt2/G9a/KMT1C to catalyze mono-
and dimethylation of lysine 9 of the histone H3 N-terminal tail in
euchromatic areas (H3K9me2) (Tachibana et al., 2005), which is an
epigenetic mark for transcriptional silencing (He and Lehming,
2003; Rice et al., 2003; Hublitz et al., 2009). Furthermore, Ehmt1
is indispensable for mouse embryonic development since homo-
zygous knockout of the gene leads to severe growth retardation
and embryonic lethality at E9.5 (Tachibana et al., 2005).
So far, studies investigating Ehmt1 function in vivo have been
focused on adaptive behavior and its role in learning and memory,
linked to the ID phenotype of KS patients. It was found that
knockout of EHMT in Drosophila led to deﬁcits in non-associative
learning and courtship memory (Kramer et al., 2011). Moreover, a
conditional knockout of Ehmt1 in postnatal forebrain revealed
deﬁcits in adaptive behavior and associative learning of mice in
the fear conditioning paradigm (Schaefer et al., 2009). We exam-
ined the Ehmt1þ / mice with Ehmt1 haploinsufﬁciency from
development on, and found that these mice display autistic-like
features and deﬁcits in learning and memory, together with
reduced branching and spine density of hippocampal CA1 neurons
and synaptic transmission defects (Balemans et al., 2010, 2013).
The KS phenotype is characterized by (1) moderate to severe
developmental delay. This term is used to characterize the devel-
opmental status of children under age three, because their
cognitive abilities are difﬁcult to assess (Daily et al., 2000). Further
KS core features are (2) childhood hypotonia causing feeding
difﬁculties, speech delay, motor delay, and (3) craniofacial
abnormalities, including micro- or brachycephaly, hypertelorism,
synophrys or arched eyebrows, mid-face hypoplasia, a short nose
with upturned nares, a protruding tongue with everted lower lip,
upslanted palpebral ﬁssures, down turned corners of the mouth,
and prognathism (Stewart and Kleefstra, 2007; Kleefstra et al.,
2009; Kleefstra syndrome Leaﬂet “Unique”, 2009; Willemsen et al.,
2012). None of these features have yet been assessed in any of the
available models.
Mouse models for human diseases are valuable for unraveling
molecular mechanisms and pathogenesis, identifying phenotypic
features that have gone unnoticed in patients, and developing
potential therapeutic interventions. Ideally, the mouse model
should be based on a known genetic cause for the disease
(construct validity), recapitulate the human phenotypes (face
validity), and respond with the same speciﬁcity to treatments that
are effective in the human disease (predictive validity) (Chadman
et al., 2009). In this study we employed Ehmt1þ / mice as a model
with construct validity, to investigate whether these mice recapi-
tulate developmental features of the KS core phenotype. We show
that in addition to ID and autistic-like features (Balemans et al.,
2010, 2013), Ehmt1þ / mice manifest several developmental
defects reminiscent of KS. Moreover, we reveal a possible mole-
cular mechanism for the morphometric skull anomalies by show-
ing that diminished Ehmt1 protein levels and reduced H3K9
dimethylation at bone developmental gene promoter sites, is
associated with increased Runx2 and other bone genes mRNA
expression in Ehmt1þ / mice.
Animals, materials and methods
Animals and genotyping
Male Euchromatin histone methyltransferase heterozygous
knockout (Ehmt1þ /) mice (Tachibana et al., 2005) were bred
with female C57BL/6J wildtype mice to obtain wildtype and
Ehmt1þ / littermates. Mice were genotyped, and housed, as
previously described (Balemans et al., 2010). The early postnatal
tests were performed before genotyping, thus the entire litter was
tested. During testing the mouse pups were identiﬁed by marking
them with a dye, and at postnatal day (P) 28 a small ear
perforation was taken for genotyping and identiﬁcation during
adulthood. All experiments were performed in a blinded fashion.
All procedures involving animals were approved by the Animal
Care Committee of the Radboud University Nijmegen Medical
Centre, The Netherlands, and conform to the guidelines of the
Dutch Council for Animal Care and the European Communities
Council Directive 2010/63/EU.
Early postnatal morphological development
Morphological development of the wildtype and Ehmt1þ /
mouse pups was assessed in three cohorts by three different
observers. The weight (g) of the pups was recorded daily from
P5 until P25. Furthermore, we recorded the postnatal day at
which: (1) nipples were visible in the female pups, (2) the pups
had a full grown fur, (3) the lower incisors erupted, (4) the upper
incisors erupted, (5) the ears opened and became functional, and
(6) the eyes opened. Ear function was assessed by administering
an acoustic stimulus and noting the presence/absence of a startle
response in the pup. If the two eyes opened at different days, the
average was taken.
Early postnatal muscular strength and motor coordination
We used two behavioral tests for muscular strength and motor
coordination (van der Meer et al., 1999) in the newly born wild-
type and Ehmt1þ / mice. The walking test was performed in four
cohorts, and the bar holding test in three cohorts by different
observers. The mouse pups were scored individually according to
four levels each for walking and bar holding. Walking levels were
deﬁned as follows: (0) no locomotion; (1) pivoting using head and
forelimbs only; (2) crawling with abdomen touching surface;
(3) walking on four limbs. Bar holding levels were deﬁned as
follows: (0) cannot hold onto bar; (1) holds bar with forepaws
only; (2) holds bar with four paws; (3) holds bar with all paws and
tail. For both tests, we scored the postnatal day at which the pup
reached level 1, 2 or 3. During the bar holding test, we recorded
the time (s) the pup was able to hang onto the bar at each
postnatal day. During the walking test in the last cohort, we
speciﬁcally assessed the way of walking. Shaking and unstable
walking was noted as ‘present’ if it occurred at least once between
P4 and P11.
Morphometric analysis and inspection of the crania
Wildtype (n¼13) and Ehmt1þ / (n¼12) female mice of 14
months old were sacriﬁced, their heads de-skinned and soft tissue
removed as much as possible with a scalpel. Crania were further
cleaned by placing them for 3 h in 60 1C water containing sodium
carbonate (200 g/l). After removing the last remaining tissue,
crania were rinsed with water and then air-dried. We measured
10 linear distances with ﬁve hundredth of a millimeter accuracy
using a vernier caliper. Each distance was measured twice by two
independent observers, and these four scores were then averaged.
We measured nasal bone length (NL), frontal bone length (FL),
parietal bone length (PL), interparietal bone length (IL), nasal bone
width (NW), distance between left and right anterolateral corner
of the frontal bone (LR), frontal bone width (FW), and interparietal
bone width (IW), as adopted from (Kawakami and Yamamura,
2008). Total cranial length (TL, measured as the distance between
the upper incisors and the occipital bone) and parietal bone width
(PW) were recorded as well. Complete or incomplete fusion of the
left and right frontal bones was assessed by visual inspection, with
the crania placed on a light box with light coming from
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underneath. The absence or presence of a bent nose, characterized
by Z151 deviation from the midline, was assessed at the time of
dissection in postnatal P2, P4, P8, P14 mice (n¼5 per age, per
genotype), and in adult wildtype (n¼49) and Ehmt1þ / (n¼51)
mice at the age of 1, 3, 6, 14, 16 or 23 months (Table 1).
Preparation of histological sections and haematoxylin/eosin (HE)
staining
Mice were sacriﬁced by cervical dislocation at the age of 5 days,
1 mo or 3 mo. P5 whole heads were frozen in liquid nitrogen, stored
at 80 1C, and sagittal 10 mm sections could be cut on the cryostat
without previous decalciﬁcation. For the adult mice, the head was
de-skinned and the entire skull cleaned off soft tissue. The P28 skulls,
containing the parietal and frontal bones, were dissected and ﬁxed in
4% paraformaldehyde, decalciﬁed in 10% EDTA for 2 days, embedded
in parafﬁn and cut coronally at 7 mm thickness. The two nose bone
pieces were taken from the skull of the 3 mo old mice and decalciﬁed
in 10% EDTA for 2 days. Using Shandon M-1 embedding matrix
(Thermo Scientiﬁc) and a cryostat at 20 1C, horizontally oriented
nose bone pieces were cut at 10 mm thickness and captured on
Superfrost Plus slides (Thermo Scientiﬁc).
P5 head and adult skull and nose bone sections were stained
with haematoxylin for 10–20 min, rinsed with running tap water
for 7 min, dipped in 50% ethanol, and stained with eosin for 1–
2 min. Sections were then dehydrated with increasing ethanol
concentrations, cleared in xylene, and mounted with Pertex
(Histolab Products AB, Göteborg, Sweden).
Westen blot analysis and immunocytochemistry
Western blot analysis for Ehmt1 protein was performed on P28
brain tissue of wildtype and Ehmt1þ / mice, as previously
described (Balemans et al., 2013).
Ehmt1 immunostaining
Sections were ﬁxed and permeabilized with ice-cold methanol
for 10 min at 20 1C and washed four times with TBS-T (50 mM
Tris–HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20). Immunocyto-
chemical staining was performed according to the UltraTek HRP
Anti-Polyvalent Staining System from ScyTek (ScyTek Laboratories,
Inc.). Brieﬂy, sections were incubated with Super Block for 5 min,
followed by a short wash with TBS-T, and overnight incubation
with mouse-anti-Ehmt1 antibody (1:200, ab41969, Abcam) in
blocking buffer (1% bovine serum albumin, 1% glycine in TBS-T)
at 4 1C. After four 10 min washes with TBS-T, the sections were
incubated for 10 min with UltraTek Anti-Polyvalent, washed four
times with TBS-T, and incubated for 10 min with UltraTek HRP.
Three TBS-T washes were followed by two TB washes (50 mM
Tris–HCl pH 7.5) and a 10 min incubation with 3,30-diaminobenzi-
dine (DAB). The DAB reaction was stopped by three more washes
with TB. Sections were then dehydrated with increasing ethanol
concentrations, cleared in xylene, and coverslipped with Pertex
(Histolab Products AB, Göteborg, Sweden).
Osteopontin immunostaining
Sections were ﬁxed and permeabilized with ice-cold methanol for
10 min at 20 1C, washed four times 5 min with PBS-T (0.1 M PBS,
0.1% Tween-20), and incubated with blocking buffer (1% bovine
serum albumin, 1% glycine in PBS-T) for 30 min. Rabbit anti-
osteopontin (1:1000, Sigma) in blocking buffer was then applied
and incubated overnight at 4 1C. After a three times 5 min rinse in
PBS-T, the sections were incubated with a donkey-anti-rabbit bioti-
nylated secondary antibody (1:250, Jackson ImmunoResearch
Laboratories) in blocking buffer for 1 h, followed by three times
5 minwash in PBS-T. The avidin–biotin complex solution (1:125; ABC
Vectastain Elite, Sigma) in PBS was made 30 min prior to use,
sections were incubated for 30 min, and rinsed three times 5 min
in PBS. Finally, the slides were placed into the 3-amino-9-
ethylcarbazole (AEC) substrate solution (0.02% AEC in N,N-dimethyl-
formamide and 0.01% H2O2 in 35 mM NaAc-HAc, pH 4.9) for 10 min.
The reaction was stopped by rinsing with distilled water. Sections
were coverslipped using Kaiser0s gelatin–glycerol.
Runx2 immunostaining
The ﬁxed and parafﬁn skull bone sections were de-parafﬁnized,
washed with PBS (0.1 M PBS), incubated with blocking buffer for 1 h
(5% rabbit serum, 5% fetal calf serum, 0.1% Triton X-100), and incubated
with primary antibody goat anti-Runx2 (1:80, Sigma) in blocking
buffer overnight at 4 1C. After three times 5 min wash in PBS, the
sections were incubated with a rabbit-anti-goat biotinylated secondary
antibody (1:250, Jackson ImmunoResearch Laboratories) in blocking
buffer for 30 min, followed by three times 5 min wash in PBS. The
avidin–biotin complex solution (1:125; ABC Vectastain Elite, Sigma) in
PBS was made 30min prior to use, sections were incubated for
30 min, and rinsed three times 5 min in PBS. Finally, DAB substrate
solution (with 10 ml H2O2) was added for 10 min, after which the
reaction was stopped by rinsing with distilled water. Sections were
dehydrated and coverslipped. Using Fiji (Image J) software, Runx2
immunostaining density was measured for 60 osteoblasts and
60 osteocytes in wildtype and Ehmt1þ / skull sections, positioned
adjacent on one glass slide. The density values (range 0–256) have
been reversed by subtracting from 256, with dark osteoblasts at
115–122 and lighter osteocytes at 70–80.
RNA isolation
For expression analysis in brain tissue, both hippocampi of P28
wildtype (n¼4) and Ehmt1þ / mice (n¼4) were quickly dissected,
frozen in liquid nitrogen and stored at 80 1C. RNAwas isolated using
the NucleoSpin RNA II (Clontech, 740955) kit according to the
manufacturer0s protocol. cDNA was synthesized from 1.0 μg total
RNA using SuperScript II reverse transcriptase (Invitrogen), and stored
at 20 1C.
For expression studies in bone tissue, the parietal and frontal skull
bones were dissected from P28 (wildtype n¼9, Ehmt1þ / n¼9) and
P8 (wildtype n¼7, Ehmt1þ / n¼3) mouse crania. After thorough
removal of all soft tissue using a scalpel knife, the cleaned skull bones
were snap frozen in liquid nitrogen and stored at 80 1C. Frozen bone
tissue was crushed in a dismembrator capsule, containing a ball,
Table 1
Number of adult wildtype and Ehmt1þ / mice without or with a bent nose.
Straight Bent Age in months
Nose Nose
(n) (n) (n straight nose)
Male wildtype 14 0 1mo (8), 3mo(6)
Female wildtype 35 0 1mo (10), 3mo (5), 6mo (7), 14mo (13)
Total wildtype 49 0
(n) (n) (n Straight nose; n bent nose)
Male Ehmt1þ / 12 9 1mo(5;4), 3mo(1;2), 6mo(0;1),
16mo(3;1), 23mo(3;1)
Female Ehmt1þ / 21 9 1mo(6;1), 3mo(4;2), 6mo(3;2), 14mo(8;4)
Total Ehmt1þ / 33 18n
Skulls of adult mice with ages ranging from 1 to 23 months old were analyzed for
the absence or presence of a “bent nose”, which was characterized by a deviation of
Z151 from the nose bones midline. This table includes the 13 wildtype and
12 Ehmt1þ / mice (14 months of age) used for the morphological skull
measurements.
n Signiﬁcantly different from wildtype (Chi-square test po0.001).
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chilled with liquid nitrogen, at 1500 rpm for 1 min. RNAwas extracted
using the RNeasy Mini Kit for ﬁbrous tissue (Qiagen, Inc., Valencia, CA,
USA, nr 74704), treated with DNAse1 (Invitrogen), and reverse
transcribed using M-MLV RT with oligo(dT) primers (Invitrogen) to
produce cDNA, stored at 20 1C.
Quantitative real-time PCR analysis
Quantitative PCR primers were designed using Primer3 (http://
www.frodo.wi.mit.edu; for list of primers used see Supplemental Table
S1), and qPCR reactions were performed in the 7500 Fast Real Time
PCR System apparatus (Applied Biosystems) by using iQ SYBR Green
Supermix (Biorad) according to the manufacturer0s protocol. Relative
mRNA expression levels for Runx2, Col22a1, Col11a1, and Dmp1 were
calculated using the 2ΔΔCt method (Livak and Schmittgen, 2001) with
standardization to Srp9 (Signal recognition particle 9) expression
levels. The difference in mRNA expression of each gene betweenwild-
type and Ehmt1þ / mouse tissue samples is depicted as fold increase
(f.i., 1.4x for Runx2) with wildtype relative mRNA levels set at 1.
H3K9me2 chromatin immunoprecipitation (ChIP)
The hippocampi of three P28 wildtype and three P28 Ehmt1þ /
mice were quickly dissected and pooled (to obtain sufﬁcient
amounts of DNA) per genotype, and subsequently treated with
1% formaldehyde to crosslink chromatin followed by tissue homo-
genization in PBS. The crosslinked chromatin was fragmented by
sonicating three times for eight minutes at high power for 30 s on/
off with a Bioruptor (Diagenode). Chromatin immunoprecipitation
(ChIP) was performed as described (Kramer et al., 2011), to capture
antibody-bound chromatin by using anti-H3K9me2 antibody (07–
441, Upstate) and Prot A/G beads (Santa Cruz). The enriched
ChIPed DNA was quantiﬁed by Qubit ﬂuorometer, using the
Quant-iT dsDNA HS Assay Kit (Invitrogen, Q32851) and analyzed
by subsequent quantitative real-time PCR (qPCR) reactions. To
perform qPCR, various primers were designed (using Primer3; for
list of primers used see Supplemental Table S1) around the
promoter of genes from 0.5 kb upstream to 1.0 kb downstream
of the transcription start site at an interval of about 250 bp.
For analysis the 0.5 to þ1.0 kb region around the transcrip-
tional start sites was targeted as previous studies have revealed
that this region encompasses H3K9me2 proﬁles controlled by
Ehmt (Barski et al., 2007; Marks et al., 2009; Kramer et al.,
2011). The β-actin promoter region was used here as a reference.
Statistical analyses
All data are presented as means7SEM. The statistical signiﬁcance
of differences between groups was assessed using the independent
samples t-test, ANOVA repeated measures test, or Chi-square test. All
statistical procedures were performed using the SPSS 17.0 and 20.0
software packages. Statistical signiﬁcance was set at po0.05.
Results
Ehmt1þ / mouse pups demonstrate delayed postnatal development
KS patients are characterized by developmental delay (Daily
et al., 2000;Iwakoshi et al., 2004;Stewart and Kleefstra, 2007).
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Fig. 1. Postnatal developmental delay in Ehmt1þ / mice. Wildtype (n¼52) and Ehmt1þ / (n¼52) pups were weighed daily from postnatal day 5–25, with Ehmt1þ / pups
showing a signiﬁcantly lower weight at each postnatal day (A). Compared with wildtypes, the Ehmt1þ / mice showed a 50% reduction of Ehmt1 protein levels in P28 brain
tissue, with γ-tubulin used as a loading control (B). Nipple development was comparable between wildtype (n¼17) and Ehmt1þ / (n¼23) female pups. Also the day the
pups had a full grown fur, and the lower incisors erupted were equal for both genotypes (wildtype n¼42 and Ehmt1þ / n¼44; C). At later developmental stages, we
observed signiﬁcantly delayed upper incisor eruption, ear opening, and eye opening in Ehmt1þ / (n¼44) pups compared with wildtype (n¼42; D). *¼signiﬁcantly different
from wildtype.
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We assessed postnatal development in wildtype and Ehmt1þ /
mouse pups. Body weight was measured daily from postnatal day
P5 until P25. Both genotypes gained weight over time, but the
body weight of Ehmt1þ / mice was signiﬁcantly reduced at every
postnatal day when compared with wildtypes (Fig. 1A, t-tests for
every single timepoint: po0.001; ANOVA repeated measures,
genotype age: F1,102¼39.621, po0.001). When Ehmt1þ / mice
reach adulthood, however, the average body weight is similar to
that in wildtypes (Balemans et al., 2010, 2013), indicating that the
observed reduction in body weight is speciﬁc for neonatal
development. This is in accordance with the recently reported
high Ehmt1 protein levels at postnatal day 4, which declined to
50% at P8, to 25% at P14, and to 10% of the P4 level by the time the
animals were 1 month old (Balemans et al., 2013). Compared
with wildtype, the Ehmt1þ / mice demonstrated 50% Ehmt1
protein reduction at all times analyzed and is shown here for P28
brain tissue (Fig. 1B).
During the ﬁrst two postnatal weeks, mice develop a fur, lower
and upper incisors appear, the ears and eyes open, and fe-
males develop nipples. When assessing these parameters in
Ehmt1þ / mice, we noted that the earlier developmental changes
(nipple development, fur formation, and lower incisor eruption)
were similar between the genotypes (Fig. 1C). At later postnatal days,
however, Ehmt1þ / pups showed a signiﬁcantly delayed onset of
1 to 2 days of upper incisor eruption (po0.001), ear opening
(po0.009), and eye opening (po0.001), compared with wildtype
(Fig. 1D). These data indicate delayed postnatal development in
Ehmt1þ / pups.
Ehmt1þ / mouse pups show hypotonia
Another core feature of KS is childhood hypotonia. To assess this in
the Ehmt1þ / mice we performed two tests for muscular function.
Walking behavior was studied from P4 until P11 according to three
different levels of maturity. At P4 all pups had already reached walking
level 1. Interestingly, Ehmt1þ / pups reached both walking level 2 and
3 almost one full day later than wildtype pups (po0.008 and
po0.006 respectively, Fig. 2A). In a part of the cohort, we closely
assessed the way of walking, which revealed a signiﬁcantly higher
percentage of Ehmt1þ / mice displaying a shaking and unstable way
of walking (χ21¼7.738, po0.005, Fig. 2B).
Bar holding ability was tested from P11 until P19. Compared
with wildtype, Ehmt1þ / pups reached each level of bar holding
almost half a day later, although this only reached signiﬁcance for
level 1 (po0.007, Fig. 2C). The amount of time the pups were able
to hang on to the bar was also measured. Bar holding time
increased over days for both genotypes, however Ehmt1þ / pups
showed signiﬁcantly decreased bar holding times compared with
their wildtype littermates (F1,68¼11.980, po0.001, Fig. 2D).
Together, these data show early postnatal hypotonia and motor
function delay in Ehmt1þ / mouse pups.
Ehmt1þ / mice have cranial abnormalities
Cranial and facial characteristics are important determinants
for the clinical diagnosis of KS. To determine whether the Ehmt1þ /
 mice have similar morphological anomalies, the lengths and the
widths of the different cranial parts were measured (Fig. 3A and
B). The length of the entire skull, and the nasal bone, frontal bone
and parietal bone length were signiﬁcantly shorter in 12 Ehmt1þ /
mice when compared with 13 wildtypes (TL: po0.001, NL:
po0.03, FL: po0.009, PL: po0.0001; Fig. 3A). The width of the
occipital bone was smaller (IW: po0.006), whereas the width of
the frontal bone and between its anterolateral corners was
signiﬁcantly wider in Ehmt1þ / mice (FW: po0.02; LR:
po0.0001, Fig. 3A and B). When taking into account the shorter
and wider crania (deﬁned as brachycephaly), the shorter nasal
bone length, and the wider LR distance (which causes the eyes to
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Shaking/unstable walking was noted when it occurred at least once between postnatal day 4 and 11, this was signiﬁcantly more often observed in Ehmt1þ / (n¼8) compared
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Ehmt1þ / (n¼37) pups hung on to the bar signiﬁcantly shorter compared with wildtype littermates (n¼39; D). *¼signiﬁcantly different from wildtype.
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be further apart, deﬁned as hypertelorism), these data imply that
Ehmt1þ / mice indeed show cranial abnormalities that corre-
spond to those seen in KS patients.
Upon examination of the morphology of the 14 mo old mouse
crania it was noted that 4 of the 12 Ehmt1þ / crania had a bent
nose, whereas none of the 13 wildtype crania showed this (Chi-
square test χ21¼5.159, po0.023, Fig. 4, Table 1). To conﬁrm this
observation, we assessed the absence or presence of the bent nose
phenotype in a larger group of mice at different ages and of
different generations. At the postnatal age of P2, P4, P8 or P14
(n¼5 per age, genotype) skull observations revealed no bent nose
in wildtypes or Ehmt1þ / mice. However, 35% of the 51 adult
Ehmt1þ / mice showed a bent-nose phenotype compared with
none of the 49 adult wildtypes (Chi-square χ21¼21.090, po0.001;
Table 1). This accounted for the adult age range of 1–23 months.
For the 18 bent noses (Table 1), deviation of snout direction
occurred equally to the left or to the right.
In addition, one of the Ehmt1þ / crania showed a large hole
along the midline which meant an incomplete fusion of the left
and right frontal bones (see Fig. 3B, and arrow in Fig. 4D). More
detailed investigation revealed a small hole between the frontal
bones (posterior region) in 2 of the 13 wildtype and 9 of the 12
Ehmt1þ / mice. Concluding, signiﬁcantly more Ehmt1þ / mice
showed incomplete posterior frontal suture fusion compared with
wildtype animals (Chi-square χ21¼9.000, po0.003; Fig. 4). Lateral
view examination of the left and right snout parts of the 25 skulls
revealed a normal, interdigitated, premaxillary suture (Fig. 3C)
between the maxillary bone and premaxilla bone, in both geno-
types (not shown).
Ehmt1 protein is present in postnatal and adult osteocytes and
osteoblasts
The bent-nose phenotype like in the Ehmt1þ / mice has also
been observed in other mouse models, including the Apert
syndrome Fgfr2 mutant mouse and Saethre-Chotzen syndrome
twist-null mouse (Bourgeois et al., 1998;Yin et al., 2008). Therefore,
we hypothesized that the distorted crania in Ehmt1þ / mice could
be caused by aberrant expression of bone tissue related genes.
For this, it was investigated whether the Ehmt1 protein was
present in bone cells. The osteopontin bone tissue marker revealed
the location of osteoblasts and osteocytes in P5 wildtype and
Ehmt1þ / cranial bone tissue (Fig. 5A and B). Haematoxylin and
eosin (HE) staining of P5 mouse head showed developing bone
with surrounding connective tissue, striated muscle cells and hair
follicles (Fig. 5C and F). Using anti-Ehmt1 immunostaining it was
demonstrated that Ehmt1 protein was indeed present in osteo-
blasts and osteocytes of P5 wildtype and Ehmt1þ / cranial tissue
(Fig. 5D and E). Furthermore, nose bone pieces from 3 months old
wildtype and Ehmt1þ / mice contained osteocytes, as shown by
osteopontin and HE staining (Fig. 5G and I). Osteocytes and
osteoblasts in 3 months old nose bone tissue clearly contained
Ehmt1 protein, both in wildtype and Ehmt1þ / mice (Fig. 5J and
K). Of note, no immunoreactivity was observed when the primary
antibody for Ehmt1 was omitted (Fig. 5L). Lastly, Ehmt1 protein
expression was observed in P5 striated muscle cells (Fig. 5M),
odontoblasts of the developing tooth (Fig. 5N), and retinal cell
layers (Fig. 5O), the development of which were all delayed in
Ehmt1þ / mice (Figs. 1 and 2).
Ehmt1þ / mice demonstrate increased expression of bone tissue
related genes
Next, it was investigated whether the reported reduced Ehmt1
protein levels in Ehmt1þ / mice (Balemans et al., 2013; Fig. 1B,)
could affect the expression of bone tissue related genes, due to
decreased histone H3 lysine 9 dimethylation (H3K9me2) levels.
Notably, H3K9me2 is an epigenetic mark for transcriptional silen-
cing (Hublitz et al., 2009) and Tachibana et al. (2005) reported
diminished H3K9me2 in Ehmt1þ / stem cells. An RNA-sequencing
dataset comparing P28 wildtype and Ehmt1þ / hippocampal brain
tissue (personal communication from co-authors M. Ansar and H.
Zhou) revealed that from all the (Z1.4 ) upregulated genes, four
genes were related to bone tissue development. Performing
quantitative PCR experiments conﬁrmed the increased mRNA
levels for the four bone genes in brain tissue of Ehmt1þ / mice
when compared with wildtypes (Fig. 6A, B, C and D and D; n¼4
per genotype). Runx2 mRNA levels were 1.4 times increased
(po0.027), Col22a1 levels were 2.9 fold higher (po0.01), Col11a1
showed a 1.5 fold increase in mRNA levels (po0.075), and Dmp1
levels were 1.7 times higher (po0.001) in Ehmt1þ / tissue
Fig. 3. Morphometric analysis of wildtype and Ehmt1þ / crania. (A) For each of the
wildtype (n¼13) and Ehmt1þ / (n¼12) crania, 10 linear cranial distances are
plotted here with ﬁve hundredth of a millimeter accuracy. *¼signiﬁcantly different
fromwildtype. (B) Drawing dorsal view of a mouse skull, indicating TL total length,
PW parietal bone width, NL nasal bone length, FL frontal bone length, PL parietal
bone length, IL interparietal bone length, NW nasal bone width, LR distance
between left and right anterolateral corner of frontal bone, FW frontal bone width,
IW interparietal bone width. (C) Drawing lateral view of a mouse skull with suture
between maxillary and premaxilla bones.
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Fig. 4. Morphology of wildtype and Ehmt1þ / crania. Photographs of three representative wildtype (A and C) and Ehmt1þ / (B and D) crania, taken with light from above (A
and B) or from underneath to visualize suture openings and holes (C and D). One third of the Ehmt1þ / mice showed a bent nose phenotype, which could be to the left (*) or
to the right (**). Bar in B (for A and B) is 1 cm. The arrows in D indicate incomplete fusion of the left and right frontal bones, which was observed in the majority of the
Ehmt1þ / crania.
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(Fig. 6A B, C and D). Of note, no alterations were observed in mRNA
levels of Fgfr2 and Twist1, the two genes for which mutant alleles
give rise to a bent-nose phenotype in mice (data not shown).
Subsequently, the mRNA levels of the ﬁrst four mentioned bone
genes were assessed in parietal and frontal skull bone tissue of P8
and P28 wildtype and Ehmt1þ / mice (Fig. 6E, F, G and H).
Fig. 5. Ehmt1 protein expression in osteoblasts and osteocytes. Immunostaining for osteopontin (A, B, G and H) revealed the presence of osteoblasts and osteocytes in
postnatal day 5 (P5) cranial bone tissue of wildtype (A) and Ehmt1þ / (B) mice, and nose bone of 3 months old wildtype (G) and Ehmt1þ / (H) mice. Haematoxylin and eosin
(HE) histochemical staining visualized skull structures at P5 as shownwith low (C) and high (F) magniﬁcation, and morphology of 3 months old nose bone (I) in wildtype and
Ehmt1þ / mice. Immunostaining for Ehmt1 (D, E, J and K) indicated the presence of Ehmt1 protein in osteoblasts and osteocytes in cranial bone tissue of wildtype (D) and
Ehmt1þ / (E) P5 mice, and in nose bone of 3 months old wildtype (J) and Ehmt1þ / (K) mice. Note the absence of immunoreactivity (L), when the primary antibody for
Ehmt1 was omitted. The Ehmt1 protein was also present in skeletal muscle (M), incisor tooth (N, and inset overview) and in eye retinal cells (O, and inset overview) of P5
wildtype and Ehmt1þ / mice. The arrows point at the osteocytes, the asterisks (*) indicate the location of osteoblasts. Bar in A, B, F, G, H, I¼20 mm; bar in C¼80 mm; bar in D,
E, J, K, L¼32 mm; bar in M, N, O¼50 mm.
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Quantitative PCR analysis demonstrated similar signiﬁcant
increases in mRNA levels of Runx2 (po0.05), Col22a1 (po0.015),
Col11a1 (po0.01), and Dmp1 (po0.019) in P28 Ehmt1þ / skull
bone tissue compared with wildtype skull (Fig. 6E, F, G and H; n¼9
per genotype). Thus, gene expression of the four mentioned genes
involved in bone morphogenesis was signiﬁcantly increased both
in brain and in skull bone of Ehmt1þ / mice. No signiﬁcant
differences in mRNA levels were observed between skull bone
tissue of P8 wildtype (n¼7) and P8 Ehmt1þ / (n¼3) mice (data
not shown).
Increased mRNA levels are associated with diminished H3K9
dimethylation in Ehmt1þ / mice
We then examined whether the enhanced mRNA expression was
correlated with the alteration of H3K9me2 levels. Chromatin-
immunoprecipitation was used to determine the genomic occupancy
of H3K9me2 at around the transcription start sites of Runx2, Col22a1,
Col11a1 and Dmp1, and performed in readily available brain tissue of
P28 wildtype and Ehmt1þ / mice. The analysis was targeted to the
0.5 to þ1.0 kb region of the transcriptional start sites, as previous
studies have revealed that this region encompasses H3K9me2 proﬁles
controlled by Ehmt (Barski et al., 2007; Marks et al., 2009; Kramer
et al., 2011). A strong reduction in H3K9me2 levels was apparent at the
Runx2 and Col22a1 transcriptional start sites in Ehmt1þ / mice
compared with wildtype (Fig. 7A and B). This reduction of H3K9me2
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Fig. 6. Increased expression of bone tissue related genes in Ehmt1þ / mice.
Quantitative PCR analysis of P28 hippocampal brain tissue from Ehmt1þ / mice
(þ / , n¼4) demonstrated increased mRNA expression for Runx2 (A), Col22a1 (B),
Col11a1 (C), and Dmp1 (D) compared with wildtype mice (wt, n¼4). The qPCR
analysis of P28 skull bone from Ehmt1þ / mice (n¼9) showed signiﬁcantly
increased mRNA expression of the bone tissue related genes Runx2 (E), Col22a1
(F), Col11a1 (G), and Dmp1 (H) compared with wildtype mice (n¼9). (For Dmp1,
values are the average of n¼4 wildtype and n¼6 Ehmt1þ / mice.) *Indicates
signiﬁcantly different from wildtype.
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Fig. 7. Decreased H3K9 dimethylation of bone gene promoter sites in Ehmt1þ /
mice. The extent of histone H3 Lysine 9 dimethylation (H3K9me2) in Ehmt1þ /
mouse brain tissue, examined at the 0.5 to þ1.0 kb region around the transcrip-
tional start site of the Runx2, Col22a1 and Col11a1 genes, demonstrated a strong
reduction in % H3K9me2 recovery levels for Runx2 (A) and Col22a1 (B), and less
pronounced for Col11a1 (C), when compared with wildtypes. The β-actin promoter
region was used as a reference, with low % H3K9me2 recovery levels (A)–(C).
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was less pronounced for Col11a1 (Fig. 7C). For Dmp1, no changes in
H3K9me2 levels were observed between the genotype groups (data
not shown). The β-actin promoter regionwas used as a reference gene,
with low % H3K9me2 recovery levels (Fig. 7A, B and C). Together, this
suggests that the enhanced mRNA levels of the bone tissue related
genes, like Runx2, Col22a1 and Col11a1, resulted from the decreased
H3K9me2 levels in Ehmt1þ / mice.
Runx2 immunostaining in P28 skull bone of wildtype and Ehmt1þ /
mice
To investigate whether increased Runx2 mRNA would result in
higher Runx2 protein expression in P28 skull tissue, the presence
of Runx2 protein in bone cells from P28 wildtype and Ehmt1þ /
mice was observed in coronal 7 mm thin parafﬁn frontal skull bone
sections.
Haematoxylin and eosin (HE) histochemical staining visualized
the characteristic double plate structure of skull bone, with the
osteocytes in the bone matrix and osteoblasts in the space
between the plates, in P28 wildtype and Ehmt1þ / mice (Fig. 8A
and B). Immunostaining for Runx2 (Fig. 8C, D, E, F, G, H, I)
indicated the presence of Runx2 protein in osteoblasts and
osteocytes in skull bone tissue of P28 wildtype (Fig. 8C, E, G and
I) and Ehmt1þ / (Fig. 8D, F, H and J) mice. Shown are lateral
(Fig. 8C and D) and more central (Fig. 8E and F) portions of the
coronal skull sections. Note the dark Runx2 immunostaining
density of the aligning osteoblasts in the enlarged photographs
for wildtype and Ehmt1þ / (Fig. 8G and H). Osteocytes contained a
lighter Runx2 density as shown for wildtype and Ehmt1þ / (Fig. 8I
and J). Quantiﬁcation of Runx2 immunostaining density demon-
strated signiﬁcantly higher values for Ehmt1þ / osteoblasts (5%
increase, *po0.005) and osteocytes (12% increase, **po0.001),
compared to wildtype density values (Fig. 8K). Ectopic bone/
cartilage was observed underneath the P28 Ehmt1þ / skull
stained for HE (Fig. 8L), and shown at higher magniﬁcation with
Runx2 immunostaining (Fig. 8M), revealing an exaggerated Runx2
immunoreactivity in the cells.
Discussion
In this study we show that Ehmt1þ / mice recapitulate the
developmental delay, hypotonia, and cranial abnormalities, which
are three of the core features of Kleefstra syndrome (KS). The
reduction of Ehmt1 protein in Ehmt1þ / mice led to diminished
H3K9 dimethylation at promoter regions of bone tissue related
genes. Since expression of Runx2, Col22a1, Col11a1, and Dmp1
mRNA was enhanced, the cranial abnormalities observed in
Ehmt1þ / mice are likely caused by disturbed regulation of bone
tissue morphogenesis.
In KS patients developmental delay has been described as
speech delay or absence, delayed motor development, late erup-
tion of milk teeth, delayed eye contact and smiles, and delayed
growth rate (Stewart and Kleefstra, 2007; Kleefstra syndrome
Leaﬂet “Unique”, 2009; Kleefstra et al., 2009). In agreement with
this, we noted a signiﬁcant delay of ear and eye opening, upper
incisor eruption, and postnatal growth in Ehmt1þ / mice. The
latter observation of reduced body weight and growth is in line
with the fatal growth retardation of full knockout Ehmt1 /
embryo0s (Tachibana et al., 2005). In addition, we recently
reported that Ehmt1 protein levels in wildtype mice were rela-
tively high at postnatal day 4, declined to 50% at P8, and
diminished further to 10% of the original P4 level by the time
the animals were 1 month old (Balemans et al., 2013), indicating
an important role for Ehmt1 in early postnatal development.
Ehmt1 protein levels remained at the 1 mo level when at 3 or
10 months of age, and, importantly, the heterozygous Ehmt1þ /
mice revealed a 50% Ehmt1 protein reduction at all postnatal
and adult times analyzed (Balemans et al., 2013). Postnatal reduc-
tion of Ehmt1 likely will affect brain and body development.
Both delayed motor development and childhood hypotonia are
characteristics of KS patients (Stewart and Kleefstra, 2007;
Kleefstra syndrome Leaﬂet “Unique”, 2009; Kleefstra et al.,
2009). Accordingly, in Ehmt1þ / mouse pups we observed delays
in reaching mature levels in two motor function tests, reduced bar
holding times, and shaking/unstable walking behavior. Notably,
these motor function deﬁcits were absent in the adult Ehmt1þ /
mice (Balemans et al., 2010, 2013).
In-depth analysis of cranial morphology revealed brachyce-
phaly, a shorter nasal bone, and hypertelorism in Ehmt1þ / mice,
thereby recapitulating the cranial abnormalities observed in
KS patients (Stewart and Kleefstra, 2007; Kleefstra syndrome
Leaﬂet “Unique”, 2009; Kleefstra et al., 2009). Similarly, mouse
models for Down syndrome and Apert syndrome, or with Tcf12 or
Erf haploinsufﬁciency, mimicked the patient0s craniofacial char-
acteristics (Richtsmeier et al., 2000; Wang et al., 2005; Yin et al.,
2008; Sharma et al., 2013; Twigg et al., 2013). The observation that
35% of the adult Ehmt1þ / crania showed a bent nose, as opposed
to 0% for adult wildtypes, is in line with the craniofacial asym-
metry noted in at least one patient with KS (Kleefstra et al., 2009).
Twist1, Fgfr2, Frem1, Tcf12, Erf, Satb2 and Il11ra mutant mouse
models for craniosynostosis display a similar bent-nose phenotype
and/or brachycephaly due to abnormal suture fusion (Bourgeois
et al., 1998; Yin et al., 2008; Vissers et al., 2011; Fish et al., 2011;
Nieminen et al., 2011; Sharma et al., 2013; Twigg et al., 2013).
Notably, in Fgfr3P244R mice the direction of nose deviation corre-
lated with ipsilateral fusion of the premaxillary suture (Twigg
et al., 2009). Another study in rats revealed that unilateral artiﬁcial
synostosis of the premaxillary suture caused the nose to bend
toward the treated side (Xenakis et al., 1995). However, in the
adult Ehmt1þ / mice with a bent nose, the premaxillary suture on
the left or the right side did not seem to be altered (CEEM Van der
Zee, own observations).
The posterior frontal suture, analogous to the metopic suture in
humans, physiologically closes between postnatal day 25–45 in
mice (Bradley et al., 1996). However, various studies reported that
this suture can remain patent later in life in both humans and mice
(Cohen, 1993; Recinos et al., 2004; Stadler et al., 2006). This was
demonstrated by the fact that only 15% of the wildtype mice
displayed a patent posterior frontal suture. Interestingly, patency
was observed in a signiﬁcantly higher percentage (75%) of
Ehmt1þ / mice. The Apert syndrome Fgfr2þ /S252W (Wang et al.,
2005) and Fgfr2 Fgfr2þ /P253R (Yin et al., 2008) mice show also
patency of the posterior frontal suture, with synostosis of the
coronal and sagittal sutures.
Bone formation is a tightly regulated process with multiple
factors controlling proliferation of osteogenic stem cells and their
differentiation during bone morphogenesis (Komori, 2010;
Miraoui et al., 2010). In this context, it is of major interest that
the P28 Ehmt1þ / mice showed signiﬁcantly increased expression
of Runx2 mRNA, and enhanced Runx2 immunostaining, in their
skull bone. This multifunctional transcription factor Runx2 con-
trols bone development by regulating the differentiation of osteo-
blasts and the expression of bone matrix protein genes during
embryonic development and in the postnatal period (Ducy et al.,
1999; Komori, 2010; Maeno et al., 2011). In addition, Runx2 needs
to be downregulated in the ﬁnal phase of bone maturation,
indicating the delicate balance for Runx2 expression regulation
(Maruyama et al., 2007; Komori, 2010). The observed increase of
Runx2 mRNA and protein in P28 Ehmt1þ / mice will affect this
balance, which might explain the observed aberrant bone forma-
tion (Maeno et al., 2011; this study). Interestingly, the lack of
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changes in bone genes mRNA expression in P8 Ehmt1þ / mice is
in line with the observation that these P8 Ehmt1þ / mice do not
contain a bent nose (yet). Importance of correct Runx2 balance has
been found in humans and mice. In humans, haploinsufﬁciency for
RUNX2 indeed caused cleidocranial dysplasia associated with
defective calvarial ossiﬁcation (Mundlos et al., 1997). After
targeted disruption of Cbfa1/Runx2 in mice complete lack of bone
formation was reported, due to maturational arrest of the osteo-
blasts (Komori et al., 1997).
The mechanism behind the observed increased mRNA expres-
sion is likely related to H3K9 methylation, a hallmark of transcrip-
tional repression (Hublitz et al., 2009). The Ehmt1/Ehmt2 (GLP/
Fig. 8. Runx2 immunostaining of P28 skull bone sections. Haematoxylin and eosin (HE) histochemical staining visualized the characteristic double plate structure of skull
bone, with the osteocytes in the bone matrix and osteoblasts in the space between the plates, in P28 wildtype (wt, (A)) and Ehmt1þ / (þ / , (B)) mice. Immunostaining for
Runx2 (C)–(J) and (M) indicated the presence of Runx2 protein in osteoblasts and osteocytes in skull bone tissue of P28 wildtype ((C), (E), (G), (I)) and Ehmt1þ / ((D), (F),
(H) and (J)) mice. Shown are lateral ((C) and (D)) and more central ((E) and (F)) portions of coronally cut frontal skull bone sections. Note the dark Runx2 immunostaining
density of the aligning osteoblasts in the enlarged photographs for wildtype (G) and Ehmt1þ / (H). Osteocytes contained a lighter Runx2 density as shown for wildtype
(I) and Ehmt1þ / (J). Quantiﬁcation of Runx2 immunostaining density demonstrated signiﬁcantly higher values for Ehmt1þ / osteoblasts (*po0.005) and osteocytes
(**po0.001), compared to wildtype (K). Ectopic bone/cartilage was observed underneath the P28 Ehmt1þ / skull as shown with haematoxylin and eosin (L), and with a
strong Runx2 staining in the cells (M). Bar in (A) (for (A)–(F)), 80 mm; bar in (G) (for (G), (H)), 20 mm; bar in (I) (for (I) and (J)), 20 mm; bar in (L), 80 mm; bar in (M), 40 mm.
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G9a) complex mediates H3K9me2 to silence transcription
(Tachibana et al., 2008). The Ehmt1þ / mice have 50% reduction
in Ehmt1 protein levels (Balemans et al., 2013), which correlated
with the diminished H3K9me2 levels at several bone gene
promoter sites in brain tissue, thereby explaining increased mRNA
expression. Pharmacological inhibition of the Ehmt1(GLP)/Ehmt2
(G9a) complex also revealed decreased H3K9me2 levels (in this
case at Zif268 and BDNF exon IV gene promoters) concomitant
with increased mRNA expression (Gupta-Agarwal et al., 2012).
Notably, postnatal and neuron-speciﬁc ablation of Ehmt1 (GLP)/
Ehmt2(G9a) led to derepression of nonneuronal genes in brain
(Schaefer et al., 2009).
In addition to Runx2, the mRNA levels of Col22a1, Col11a1 and
Dmp1were also signiﬁcantly increased in cranial bone tissue of the
Ehmt1þ / mice. The minor ﬁbrillar collagen Col11a1 is essential
for skeletal bone morphogenesis (Li et al., 1995), whereas Col22a1
is present speciﬁcally at tissue junctions, is associated with the
extraﬁbrillar matrix in cartilage, and can act as cell adhesion
ligand for ﬁbroblasts (Koch et al., 2004). Dmp1, dentin matrix
acidic phosphoprotein 1, might indirectly promote osteoblast
differentiation (Eapen et al., 2010), but is certainly critical for
proper bone matrix mineralization during bone maturation (Rios
et al., 2005; Toyosawa et al., 2001). Thus Col11a1, Col22a1, and
Dmp1 all play a role in the formation of bone tissue. The enhanced
Dmp1 mRNA expression might be regulated through lower Ehmt1
activity, although H3K9me2 levels at the Dmp1 promotor site
were not altered. A more likely explanation is an indirect regula-
tion of Dmp1 by enhanced Runx2 levels, since this transcription
factor regulates the expression of many bone tissue associated
proteins like osteopontin, Col1a1, Col10a1, and Dmp1 (Komori,
2010).
In summary, the Ehmt1þ / mice recapitulate the core features of
Kleefstra syndrome with intellectual disability, autistic-like features
(Balemans et al., 2010, 2013), developmental delay, hypotonia, and
cranial dysmorphisms (this study). Furthermore, the increased expres-
sion of bone tissue genes, and particularly Runx2, in P28 Ehmt1þ /
crania likely contributed to the craniofacial phenotype of bent nose
and brachycephaly in the Ehmt1þ / mouse model for Kleefstra
syndrome, and can be explained by less gene silencing due to
diminished Ehmt1-induced H3K9 dimethylation.
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